Drug class
Dihydroartemisinin; artemisinin-derived antimalarial endoperoxide
Mechanism of action
The endoperoxide bridge is activated by haem/iron within Plasmodium parasites, generating reactive radicals that damage parasite proteins and other cellular components. It is used in combination regimens to reduce resistance development.
General use cases
- Treatment of uncomplicated Plasmodium falciparum malaria as a component of fixed-dose artemisinin-based combination therapy (for example, dihydroartemisinin–piperaquine); not recommended as monotherapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
